Zobrazeno 1 - 10
of 451
pro vyhledávání: '"National immunization program"'
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 10, Pp 2155-2177 (2024)
Abstract Introduction Japan will be transitioning from the free-of-charge COVID-19 vaccination program to annual periodic vaccination under a national immunization program for old adults and high-risk patients from 2024 fall/winter season. The policy
Externí odkaz:
https://doaj.org/article/8bed62a875af4e43bab0846949c3e920
Autor:
Alberto Pérez, María Fernández Prada, Natalia Cassinello, Laura Amanda Vallejo-Aparicio, Andrea García, Almudena González, Ana Durán, Néboa Zozaya, Irene Fernández, Mathilde Daheron, Álvaro Hidalgo, Ekkehard Beck, Antonio García Ruiz
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Broad benefits of vaccination programs are well acknowledged but difficult to measure, especially when considering all vaccines included in a National Immunization Program (NIP). The aim was to conduct a cost–benefit analysis of the entire NIP in S
Externí odkaz:
https://doaj.org/article/a07e7f9c0aac4baaa68559c51f8f7122
Autor:
Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Ratchadawan Aeemchinda, Wichan Bhunyakitikorn, Thanawadee Thantithaveewat, Sunanta Seetho, Darunee Phosri, Naiyana Netthip, Nungruthai Suntronwong, Nasamon Wanlapakorn, Yong Poovorawan
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Thailand introduced a two-dose regimen of bivalent HPV vaccines for Grade 5 schoolgirls, approximately 11 years old, initially piloted in Ayutthaya province in 2014, and nationwide under the National Immunization Program (NIP) in 2017. This cross-sec
Externí odkaz:
https://doaj.org/article/dec43f131b204638a3e646bdfaf9dc0b
Autor:
Youngji Song, Eunha Shim
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTSouth Korea’s National Immunization Program administers the quadrivalent influenza vaccine (QIV) to manage seasonal influenza, with a particular focus on the elderly. After reviewing the safety and immune response triggered by the adjuvante
Externí odkaz:
https://doaj.org/article/96991504fcd649438f69ecace4e72c09
Autor:
Paolo Bonanni, Stefano Castagna, Giovanni Gabutti, Sandro Giuffrida, Federico Marchetti, Rocco Russo, Rosa Prato, Francesco Vitale
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTVaccine co-administration is a useful strategy for improving vaccine coverage and adherence. In Italy, an update to the national immunization program (NIP) in 2023 included recommendations for co-administration of pediatric vaccines, includin
Externí odkaz:
https://doaj.org/article/3a3fb4a75c544c598747f410bb1c0353
Autor:
Marisa Felsher, Meheret Shumet, Cristinela Velicu, Ya-Ting Chen, Kinga Nowicka, Magdalena Marzec, Gabriela Skowronek, Izabela Pieniążek
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThe uptake of human papillomavirus (HPV) vaccine remains suboptimal despite being a part of routine vaccination within national immunization program(s). This indicates probable challenges with the implementation of HPV immunization program(s)
Externí odkaz:
https://doaj.org/article/ed3e49ef85f64348ba563f62370458c4
Publikováno v:
Infectious Diseases of Poverty, Vol 13, Iss 1, Pp 1-5 (2024)
Abstract Background Immunization is a cornerstone of public health. Despite great success, China’s National Immunization Program (NIP) faces challenges, such as the integration of several World Health Organization-recommended vaccines and other sys
Externí odkaz:
https://doaj.org/article/4f6e9766459541698d91c7ba75891822
Publikováno v:
Globalization and Health, Vol 20, Iss 1, Pp 1-16 (2024)
Abstract Introduction Indonesia has made progress in increasing vaccine coverage, but equitable access remains challenging, especially in remote areas. Despite including vaccines in the National Immunization Program (NIP), coverage has not met WHO an
Externí odkaz:
https://doaj.org/article/a90daa6040c44254ad5f1b0ad99265c3
Publikováno v:
Infectious Diseases of Poverty, Vol 13, Iss 1, Pp 1-11 (2024)
Abstract Many countries have adopted higher-valent pediatric combination vaccines to simplify vaccination schedules and minimize health expenditures and social costs. However, China is conservative in the use of pediatric combination vaccines. By rev
Externí odkaz:
https://doaj.org/article/a19cbc358fb84d2687f31331130aa8d1
Publikováno v:
Vaccine: X, Vol 18, Iss , Pp 100484- (2024)
Background: Diphtheria-tetanus-acellular pertussis, polio, and Haemophilus influenza type B (DTaP-IPV/Hib) combination vaccine was introduced as a part of the Korea National Immunization Program (NIP) on June 19, 2017. Combination vaccines can improv
Externí odkaz:
https://doaj.org/article/99a4eed318cf4380abe6b05280166923